EMN Financial Facts
Diluted earnings per share: 1.56Asset impairments and restructuring charges (gains), net: 30M
See Full Income Statement
Total current liabilities: 2.21B
Trade receivables, net: 905M
See Full Balance Sheet
Eastman Chemical Co. (EMN) Earnings
|
Expand Research on EMN
| Next EPS Date | 7/23/26 | EPS Growth Rate | +13.1% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.5% | Revenue Growth Rate | +5.2% |
| Average % Move 1-Wk after EPS | +0.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/23/26  |
Q226 | N/A | $1.81 | N/A | N/A | $2.41B | = | N/A | N/A | ||
| 4/30/26 | Q126 | $1.09 | $1.10 | -$0.01 | $2.18B | $2.17B | = |  | | Details | |
| 1/29/26 | Q425 | $0.75 | $0.75 | $0.00 | $1.97B | $2.03B | = | | | Details | |
| 11/3/25 | Q325 | $1.14 | $1.16 | -$0.02 | $2.2B | $2.26B | = | | | Details | |
| 7/31/25 | Q225 | $1.60 | $1.73 | -$0.13 | $2.29B | $2.3B | = | | | Details | |
| 4/24/25 | Q125 | $1.91 | $1.90 | +$0.01 | $2.29B | $2.35B | = | | | Details | |
| 1/30/25 | Q424 | $1.87 | $1.61 | +$0.26 | $2.25B | $2.28B | = | | | Details | |
| 10/31/24 | Q324 | $2.26 | $2.15 | +$0.11 | $2.46B | $2.38B | = | | | Details |
